Literature DB >> 17115249

Radiotherapy for rectal carcinoma: an unusual cause of foreskin phimosis.

Jonathan M Featherstone1, Andrew Aldridge, A Mark Gudgeon.   

Abstract

Phimosis of the foreskin secondary to radiotherapy for a pelvic malignancy has not been previously described in the world literature. However, as radiotherapy is ever more widely used in the treatment of various pelvic malignancies, it is important to ensure that this complication is prevented by the use of appropriate penile shielding.

Entities:  

Mesh:

Year:  2006        PMID: 17115249     DOI: 10.1007/s11255-005-4758-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Eyelid phimosis and chronic radiation dermatitis associated with iridium brachytherapy.

Authors:  J W Kronish; W F Mieler; R K Dortzbach
Journal:  Am J Ophthalmol       Date:  1988-04-15       Impact factor: 5.258

2.  Modulation of skin collagen metabolism by irradiation: collagen synthesis is increased in irradiated human skin.

Authors:  R Riekki; A Jukkola; M L Sassi; M Höyhtyä; M Kallioinen; J Risteli; A Oikarinen
Journal:  Br J Dermatol       Date:  2000-05       Impact factor: 9.302

3.  Factors influencing the severity of radiation skin and oral mucosal reactions: development of a conceptual framework.

Authors:  Davina Porock
Journal:  Eur J Cancer Care (Engl)       Date:  2002-03       Impact factor: 2.520

Review 4.  Early and late radiation-induced skin alterations. Part I: Mechanisms of skin changes.

Authors:  E Sitton
Journal:  Oncol Nurs Forum       Date:  1992-06       Impact factor: 2.172

5.  Radiation damage to the rectum and anus: pathophysiology, clinical features and surgical implications.

Authors:  E. D. Reis; A. J. Vine; T. Heimann
Journal:  Colorectal Dis       Date:  2002-01       Impact factor: 3.788

6.  Increased expression of collagen types I and III in human skin as a consequence of radiotherapy.

Authors:  Riitta Riekki; Mataleena Parikka; Arja Jukkola; Tuula Salo; Juha Risteli; Aarne Oikarinen
Journal:  Arch Dermatol Res       Date:  2002-04-27       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.